These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36446780)

  • 21. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
    Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
    Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2.
    Dale B; Anderson C; Park KS; Kaniskan HÜ; Ma A; Shen Y; Zhang C; Xie L; Chen X; Yu X; Jin J
    ACS Pharmacol Transl Sci; 2022 Jul; 5(7):491-507. PubMed ID: 35837138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a first-in-class EZH2 selective degrader.
    Ma A; Stratikopoulos E; Park KS; Wei J; Martin TC; Yang X; Schwarz M; Leshchenko V; Rialdi A; Dale B; Lagana A; Guccione E; Parekh S; Parsons R; Jin J
    Nat Chem Biol; 2020 Feb; 16(2):214-222. PubMed ID: 31819273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2 Promotes Corneal Endothelial Cell Apoptosis by Mediating H3K27me3 and Inhibiting HO-1 Transcription.
    Lin Y; Su H; Zou B; Huang M
    Curr Eye Res; 2023 Dec; 48(12):1122-1132. PubMed ID: 37800319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer.
    Leone GM; Mangano K; Caponnetto S; Fagone P; Nicoletti F
    Cells; 2024 Aug; 13(15):. PubMed ID: 39120328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming.
    Tang Y; Zhao L; Yu X; Zhang J; Qian L; Jin J; Lu R; Zhou Y
    Stem Cell Res; 2021 May; 53():102365. PubMed ID: 34087994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EZH2 T367 phosphorylation activates p38 signaling through lysine methylation to promote breast cancer progression.
    Gonzalez ME; Naimo GD; Anwar T; Paolì A; Tekula SR; Kim S; Medhora N; Leflein SA; Itkin J; Trievel R; Kidwell KM; Chen YC; Mauro L; Yoon E; Andò S; Kleer CG
    iScience; 2022 Aug; 25(8):104827. PubMed ID: 35992062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer.
    Gao B; Liu X; Li Z; Zhao L; Pan Y
    Front Oncol; 2020; 10():600514. PubMed ID: 33665162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
    Li H; Cai Q; Godwin AK; Zhang R
    Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
    Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of EZH2-mediated H3K27me3 in placental ADAM12-S expression: implications for fetoplacental growth.
    Zhu YN; Gan XW; Pan F; Ni XT; Myatt L; Wang WS; Sun K
    BMC Med; 2022 May; 20(1):189. PubMed ID: 35610640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α.
    Chen H; Yu S; Ma R; Deng L; Yi Y; Niu M; Xu C; Xiao ZJ
    Cell Death Differ; 2024 Apr; 31(4):447-459. PubMed ID: 38413797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells.
    Jiang F; Li Y; Si L; Zhang Z; Li Z
    Cell Biol Toxicol; 2019 Aug; 35(4):361-371. PubMed ID: 30612216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EZH2 regulates expression of FOXC1 by mediating H3K27me3 in breast cancers.
    Zheng XJ; Li W; Yi J; Liu JY; Ren LW; Zhu XM; Liu SW; Wang JH; Du GH
    Acta Pharmacol Sin; 2021 Jul; 42(7):1171-1179. PubMed ID: 33057161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of precision targeting EZH2 degraders for triple-negative breast cancer.
    Wang C; Chen X; Liu X; Lu D; Li S; Qu L; Yin F; Luo H; Zhang Y; Luo Z; Cui N; Kong L; Wang X
    Eur J Med Chem; 2022 Aug; 238():114462. PubMed ID: 35623249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EZH2 and histone deacetylase inhibitors induce apoptosis in triple negative breast cancer cells by differentially increasing H3 Lys
    Huang JP; Ling K
    Oncol Lett; 2017 Nov; 14(5):5735-5742. PubMed ID: 29113202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.
    Wang SH; Liu L; Bao KY; Zhang YF; Wang WW; Du S; Jia NE; Suo S; Cai J; Guo JF; Lv G
    Curr Med Sci; 2023 Aug; 43(4):794-802. PubMed ID: 37498408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.